NBIX Initiated at Outperform
Bernstein starts coverage of Neurocrine Biosciences with a positive rating, citing growth potential. This may impact the biotech sector.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.